Treatment of seminoma I stage disease;Seminom v prvním klinickém stadiu - Léč ebné možnosti

Klinicka Onkologie

Volumn 21, Issue 3, 2008, Pages 86-92

  Vyskočil, Jiři ^a   Poprach, A ^a   Petrakova K ^a   Lakomy R ^a   Vyzula, R ^a   Coupek P ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Carboplatin; Chemotherapy; Radiotherapy; Second cancer; Seminoma; Surveillance

Indexed keywords

CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; TUMOR MARKER;

CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; GASTROINTESTINAL DISEASE; GERM CELL TUMOR; GOLD STANDARD; HUMAN; INFERTILITY; ORCHIECTOMY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PROGNOSIS; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; RETE TESTIS; REVIEW; RISK FACTOR; SECOND CANCER; SEMINOMA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 46649102680     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Klener P. et al.: Klinická onkologie, Galén Praha 2002: 460.
2. Warde P., Specht L., Horwich A., et . al.: Prognostic Factors for Relapse in Stage i Seminoma Managed by Surveillance: a pooled analysis, Journal of Clinical Oncology 20: 4448-4452, 2002.
3. Klener P. et al.: Klinická onkologie, Galén Praha 2002: 461.
4. NCCN.org (internetová stránka).National Cancer Comprehensive Network (updated 1. 2008, citováno 16.1.2007). Dostupné z: http://www.nccn.org.
5. Busch F. M., Sayegh E. S., Chenault O. W.: Some Uses of Lymfangiography in the Management of testicular Tumors, Journal of Urology 93: 490-495, 1965.
6. Mason M. D., Featherstone T., Ollif J., Howich A.: Inguinal and Iliac Lymph Node Involvement in Germ Cell Tumours of the Testis: Implications for Radiological Investigation and for Therapy, Clinical Oncology 3: 147-150, 1991.
7. Mason M. D., Featherstone T., Ollif J., Howich A.: Inguinal and Iliac Lymph Node Involvement in Germ Cell Tumours of the Testis: Implications for Radiological Investigation and for Therapy, Clinical Oncology 3: 147-150, 1991.
8. Jacobsen K. D., Olsen D. R., Fossa K., Fossa S. D.: External Beam Radiotherapy in Patients with Seminoma Stage I: field type, testicular dose and spermatogenesis, International Journal of Radiation Oncology, Biology, Physics 39: 95-102, 1997.
9. Fossa S. D., Horwich A., Russel J. M., et al.: Optimal Planning Target Volume for Stage i Testicular Seminoma: a Medical Research Council randomized Trial, medical Research Council Testicular Tumor Working Group, Journal of Clinical Oncology 17(9): 1146, 1999
10. Niazi M. T., Souhami L., Sultanem K., et al.: Long - term Results of Para - aortic Irradiation for Patients with Stage i Seminoma of the Testis, International Journal of Radiation Oncology, Biology , Physics 61: 741-744, 2005.
11. Classen J., Schmidberger H., Meisner C, et al.: Para - aortic Irradiation for Stage i testicular Seminoma: results of a prospective Study in 675 Patients. A Trial of the German Testiculat Cancer Study Group, British Journal of Cancer 90: 2305-2311, 2004.
12. Jones G. W., Fossa D. S., Mead M. G., et al.: Randomized Trial of 30 Versus 20 Gy in the Adjuvant Treatment of Stage i Testicula Seminoma: a report on Medical Research Council Trial TE 18, European Organisation for the Research and Treatment of Cancer Trial 30942, Journal of Clinical Oncology 23: 1200-1208, 2005.
13. Power E. R., Kennedy J., Crown J., et.al.: Pelvic recurrence in stage i seminoma: a New Phenomenon that Questions Modern Protocols for Radiotherapy and Follow-up, International Journal of Urology 12: 378-382, 2005.
14. Šlampa P a koletiv: Radiačni onkologie v praxi, II. aktualizované vydání, Masarykův onkologický ústav, 2007:153-157.
15. Bruns F., Bremer M., Meyer A., Karstens H. J.: Adjuvant Radiotherapy in Stage i Seminoma: Is There a Role for Further reduction of Treatment Volume?, Acta Oncologica 44: 142-148, 2005.
16. Josefsen D., Fossa S., The Management Strategies for Stage i Seminoma, Clinical Oncology 17: 539-542, 2005.
17. Garcia - Serra M., A., Zlotecki R., A., Morris G., C., et al.: Long - term Results of Radiotherapy for Early - Stage Testicular Seminoma, American Journal of Clinical Oncology 28: 119-124, 2005.
18. Majewski W., Majewski S., Maciejewski A, et al: Adverse Effects after Radiotherapy for Early Stage (I, Iia, IIb) Seminoma, Radiotherapy and Oncology 76: 257-263, 2005.
19. Huddart R., A., Norman. A, Shahidi M.,et al.: Cardiovascular Disease as a Long-term Complication of Treatment for Testicular Cancer, Journal of Clinical Oncology 21: 1513-1523, 2003.
20. Yeoh E., Razali M., O'Brien P., C.: Radiation Therapy for Early Stage Seminoma of the Testis. Analysis of Survival and Gastrointestinal Toxicity in Patients Treated with Modern Megavoltage Techniques over 10 Years, Australas Radiology 37: 367-369, 1995.
21. Vallis K., A., Howard G., C., Duncan W., et al.: Radiotherapy for Stages i a II Testicular Seminoma: Results and Morbidity in 238 Patients, The British Journal of Radiology 68:400-405, 1995.
22. Klener P. et al: Vnitřni lékařství, druhé doplněné vydání, Galén, Praha 2001, 452-455.
23. Travis B., L., Fossa S. D., Schonfeld S., J., et al.: Second Cancers among 40 576 Testicular Cancers Patients: Focus on Long - Term Survivors, Journal of the National Cancer Institute 18: 1354-1364, 2005.
24. Jeffrey M., A., J., Nalesnik G., Sabanegh S. E., Buchholz T., A.: Fertility in Men After Treatment for Stage 1and a Seminoma, American Journal of Clinical Oncology 27: 584-588, 2004.
25. Fossa S., D., Abyholm T., et al.: Post - treatment Fertility in Patients with Testicular Cancer, British Journal of Urology 58: 315-319, 1986.
26. Petersen P.M., Skakkebaek N.E., Vistisen K. et al.: Semen Quality and Reproductive Hormones before Orchiectomy in Men with Testicular Cancer, Journal of Clinical Oncology 17:941, 1999.
27. Choo R., Thomas G., Woo T, et al.: Long - term Outcome of Postorchiectomy Surveillance for Stage i Testicular Seminoma, International Journal of Radiation Oncology, Biology , Physics 61: 736-740, 2005.
28. Horwich A., Alsanjari N., A'hern R et al: Surveillance Following Orchiectomy for Stage i Seminoma, British Journal of Cancer 65: 775-778, 1992.
29. Aparacio J., del Muro X. G., Maroto P., et al.: Multicenter Study Evaluating a Dual Policy of Postorchiectomy Surveillance and Selective Adjuvant Single - agent Carboplatin for Patients with Clinical Stage i Seminoma, Annals of Oncology 14: 867-872, 2003.
30. Klener P. et al.: Klinická Onkologie, Galén Praha 2002: 174.
31. Siegert W, Beyer J, Strohscheer I, et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study, Journal of Clinical Oncology12:1223, 1994.
32. Oliver R. T. D., Edmonds P. M., Ong J. Y., et al.: Pilot Studies of 2 and 1 Course Carboplatin as Adjuvant for Stage i Seminoma: Should It Be Tested in a Randomized Trial Against Radiotherapy, International Journal of Radiation Oncology, Biology , Physics 30: 3-8, 1994.
33. Reiter W. J., Brodowicz T., Alavi S., et al:Twelve Year Experience with Two Courses of Adjuvant Single - Agent Carboplatin Therapy for Clinical Stage i Seminoma, Journal of Clinical Oncology19:101-104, 2001.
34. Krege S., Kalund G., Otto T., et al: Phase II Study: Adjuvant Single Agent Carboplatin Therapy for Clinical Stage i Seminoma, European Urology, 31: 405-407, 1997.
35. Dieckman K. P., Krain J., Kuster J, et al:Adjuvant Carboplatin Treatment for Semonima Clinical Stage I, Journal of Clinical Oncology, 122: 63-66, 1996.
36. Aparacio J., Germa R.J., del Muro X.G., et al.:Risk - adapted Management for Patients With Clinical Stage i Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study, Journal of Clinical Oncology 23: 8717-8723, 2005.
37. Oliver R. T. D., Mason M. D., Mead G. M., et al.: Radiotherapy versus Single - dose carboplatin in Adjuvant treatment of Stage i Seminoma: a Randomised Trial, The Lancet 366: 293-300, 2005.
38. Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T.: The long-term risks of adjuvant carboplatin treatment for stage i seminoma of the testis, Annals of Oncology, Nov 28 (Epub ahead of print), 2007.
39. Uroweb.org (internetová stránka) European Association of Urology (updated 3. 2008, citováno 20.3.2008). Dostupné z: http://www.uroweb.org